| Literature DB >> 31025246 |
Valentina Rovella1, Manuel Scimeca2,3, Elena Giannini2, Adriana D'Ercole2, Erica Giacobbi2, Annalisa Noce1, Gabriele D'Urso1, Alessandro Anselmo4, Pierluigi Bove5, Giuseppe Santeusanio2, Elena Bonanno2, Maurizio Casasco6, Silvestro Mauriello7, Nicola Di Daniele1, Alessandro Mauriello8,9, Lucia Anemona2.
Abstract
Several evidences support the hypothesis that patients affected by autosomal dominant polycystic kidney disease (ASPKD) show a sympathetic renal hyperactivity. Nevertheless, no morphological evidences are available yet. Therefore, the aim of the study was to demonstrate that an increase in sympathetic renal artery innervation was present in the ADPKD patients by using histological methods. In addition, here we correlated the sympathetic renal artery innervation with the evolutionary state of ADPKD (increase in volume of kidney, onset of chronic renal failure and hypertension). To this end, peri-adventitial innervation of renal arteries was studied using morphological methods from 49 patients in total: 29 underwent surgical nephrectomies for ADPKD and 20 non-dialysis patients (CTRL group) undergoing nephrectomy for other diseases. Nerve density (number of nerves per mm2) was evaluated in the peri-adventitial tissue in a concentric ring that was located within 2 mm from the beginning of the adventitia by using immunohistochemistry. The total nerve density was significantly increased in the ADPKD group (1.26 ± 0.82 × mm2) as compared to controls (0.78 ± 0.40 × mm2) (p = 0.02). Hypertensive patients with ADPKD showed a greater nerve density than control hypertensives. However, the increase in renal sympathetic innervation in the ADPKD patients was found to be independent of hypertension, resistance to antihypertensive therapy, age, sex and kidney volume, as demonstrated by the uni and multivariate analysis. In conclusion, our study better clarifies the effect of sympathetic hyperactivity in the progression of polycystic disease.Entities:
Keywords: ADPKD; Histology; Renal denervation; Sympathetic renal hyperactivity
Mesh:
Year: 2019 PMID: 31025246 DOI: 10.1007/s40620-019-00612-3
Source DB: PubMed Journal: J Nephrol ISSN: 1121-8428 Impact factor: 3.902